Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430905
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-17
Brief Title:
Safety Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
Sponsor:
Hookipa Biotech GmbH
Organization:
Hookipa Biotech GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-17
First Submit QC Date:
May 24 2024
Study First Post Date:
2024-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL